Tg Therapeutics

TGTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.617 B

$49.76 +0.42%

Close of 7 Aug 2026

Revenue

$616.3M

#1802 by revenue

Earnings

$447.2M

#659 by earnings

Shares outstanding

153,069,053

Latest filing cover page

P/E ratio

17.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#44LiquidiaLQDA$8.02B
#45Rhythm PharmaceuticalsRYTM$7.96B
#46Tg TherapeuticsTGTX$7.62B
#47Cogent BiosciencesCOGT$7.24B
#48Mirum PharmaceuticalsMIRM$6.54B

Where these numbers come from

Share counts and financials for Tg Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.